SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Indications -- Psoriasis/Chronic Inflammation
An SI Board Since February 2001
Posts SubjectMarks Bans
631 42 0
Emcee:  scaram(o)uche Type:  Moderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
606finance.yahoo.com Amgen and Xencor Enter Option Deal to Co-Develop Xencor'sscaram(o)uche-1/6/2011
605Blood. 2010 Oct 22. [Epub ahead of print] A novel role for IL-22R1 as a driver scaram(o)uche-10/28/2010
604J Immunol. 2010 Oct 13. [Epub ahead of print] IDO Upregulates Regulatory T Cellscaram(o)uche-10/22/2010
603Arthritis Patient Successfully Treated With Fat Stem Cells Tells His Story markrusset-6/28/2010
602<b>Psoriasis market</b> nature.com Irena Melnikova1 Psoriasis is idos-10/2/2009
601Safety concerns give Raptiva 'no way back' Monday , March 02, 2009 RaptIcebrg-3/2/2009
600Top five advances in psoriasis research psoriasis.orgsoftware salesperson-1/20/2009
599Advances in biologics Up-and-coming biologic shows great promise for treating plIcebrg-1/18/2009
598<b>New genetic markers for ulcerative colitis identified, researchers repoidos-1/5/2009
597reported today that LTbetaR-Ig failed in the clinic (BIIB) for RA...... Mol Immscaram(o)uche-10/9/2008
596J&J Touts Psoriasis-Drug Data By PETER LOFTUS [WSJ] [SEPTEMBER 19, 2008] Jsim1-9/19/2008
595Efficacy of ISA247 in plaque psoriasis: a randomised, multicentre, double-blind,teevee-4/19/2008
594Researchers find immune drug safely treats psoriasis Thu Apr 17, 2008 6:33pm EDTteevee-4/17/2008
593Whole genome association study of psoriasis mednews.wustl.eduMike McFarland-4/6/2008
592<b>Early combined immunosuppression or conventional management in patientsidos-2/25/2008
591Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a motnsaf-1/7/2008
590From Natur, Vol 450|29 November 2007 <b>Fever pitch</b> The push fidos-11/30/2007
589Rheumatoid arthritis patients' mortality unchanged Mon Oct 29, 7:19 PM ET NEnigel bates-10/30/2007
588Major genetic breakthrough for ankylosing spondylitis brings treatment hope 18:0nigel bates-10/22/2007
587Abbott's ABT-874 Shows Positive Results for Maintenance of Response in Phasenigel bates-10/1/2007
586Fourth ACTEMRA(TM) (tocilizumab) Phase III Study Demonstrates Significant Clinicnigel bates-7/25/2007
585Xencor Data Published in Journal of Immunology Demonstrate Selectivity of New Clnigel bates-7/23/2007
584Roche and Toyama Chemical Enter Licensing Agreement to Develop Potential Breakthnigel bates-6/25/2007
583MabThera shows stable long-term arthritis safety reuters.com Wed Jun 13, 2007 teevee-6/14/2007
582Public release date: 14-Jun-2007 Contact: Bonnie Ward contact@liai.org 619-303-Ian@SI-6/14/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):